Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1967 Nov 11;97(20):1222–1224.

Dissociative delirium after treatment with lysergide.

R Denson
PMCID: PMC1923613  PMID: 6054295

Full text

PDF
1222

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CHARALAMPOUS K. D., KINROSS-WRIGHT J. HALLUCINOGENS. TOOLS FOR RESEARCH OR THERAPEUTIC AGENTS. Tex Med. 1963 Sep;59:848–852. [PubMed] [Google Scholar]
  2. COHEN S., DITMAN K. S. Prolonged adverse reactions to lysergic acid diethylamide. Arch Gen Psychiatry. 1963 May;8:475–480. doi: 10.1001/archpsyc.1963.01720110051006. [DOI] [PubMed] [Google Scholar]
  3. COHEN S., EISNER B. G. Use of lysergic acid diethylamide in a psychotherapeutic setting. AMA Arch Neurol Psychiatry. 1959 May;81(5):615–619. doi: 10.1001/archneurpsyc.1959.02340170081008. [DOI] [PubMed] [Google Scholar]
  4. Denson R. Lysergide in the treatment of neurosis. (A report of two cases). Dis Nerv Syst. 1966 Aug;27(8):511–514. [PubMed] [Google Scholar]
  5. EISNER B. G., COHEN S. Psychotherapy with lysergic acid diethylamide. J Nerv Ment Dis. 1958 Dec;127(6):528–539. doi: 10.1097/00005053-195812000-00006. [DOI] [PubMed] [Google Scholar]
  6. Fink M., Simeon J., Haque W., Itil T. Prolonged adverse reactions to LSD in psychotic subjects. Arch Gen Psychiatry. 1966 Nov;15(5):450–454. doi: 10.1001/archpsyc.1966.01730170002002. [DOI] [PubMed] [Google Scholar]
  7. Frosch W. A., Robbins E. S., Stern M. Untoward reactions to lysergic acid diethylamide (LSD) resulting in hospitalization. N Engl J Med. 1965 Dec 2;273(23):1235–1239. doi: 10.1056/NEJM196512022732302. [DOI] [PubMed] [Google Scholar]
  8. GEERT-JOERGENSEN E., HERTZ M., KNUDSEN K., KRISTENSEN K. LSD-TREATMENT. EXPERIENCE GAINED WITHIN A THREE-YEAR-PERIOD. Acta Psychiatr Scand. 1964;40:SUPPL 180–180:373+. doi: 10.1111/j.1600-0447.1964.tb04949.x. [DOI] [PubMed] [Google Scholar]
  9. LING T. M., BUCKMAN J. The use of lysergic acid in individual psychotherapy. Proc R Soc Med. 1960 Nov;53:927–929. doi: 10.1177/003591576005301107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. LUDWIG A. M., LEVINE J. A CONTROLLED COMPARISON OF FIVE BRIEF TREATMENT TECHNIQUES EMPLOYING LSD, HYPNOSIS, AND PSYCHOTHERAPY. Am J Psychother. 1965 Jul;19:417–435. doi: 10.1176/appi.psychotherapy.1965.19.3.417. [DOI] [PubMed] [Google Scholar]
  11. ROSENTHAL S. H. PERSISTENT HALLUCINOSIS FOLLOWING REPEATED ADMINISTRATION OF HALLUCINOGENIC DRUGS. Am J Psychiatry. 1964 Sep;121:238–244. doi: 10.1176/ajp.121.3.238. [DOI] [PubMed] [Google Scholar]
  12. SANDISON R. A. HALLUCINOGENS. Practitioner. 1964 Jan;192:30–36. [PubMed] [Google Scholar]
  13. SAVAGE C. The resolution and subsequent remobilization of resistance by LSD in psychotherapy. J Nerv Ment Dis. 1957 Jul-Sep;125(3):434–437. doi: 10.1097/00005053-195707000-00015. [DOI] [PubMed] [Google Scholar]
  14. STEVENSON I. Comments on the psychological effects of mescaline and allied drugs. J Nerv Ment Dis. 1957 Jul-Sep;125(3):438–442. doi: 10.1097/00005053-195707000-00017. [DOI] [PubMed] [Google Scholar]
  15. WALTHER-BUEL H. Uber Pharmakopsychiatrie. Schweiz Med Wochenschr. 1953 May 23;83(21):483–487. [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES